🟢 Icecure Medical is trading 6.53% up in pre-market as Nasdaq futures rise approximately 0.68%

Icecure Medical is trading 6.53% up at $2.12 in pre-market, apparently driven mainly by constructive broader-market sentiment.

• No new company-specific announcement or overnight filing was identified for September 18, 2026.
• The latest major company news was September 10 regulatory approval to market ProSense in China, not a new catalyst today.
• S&P 500 futures are up about 0.38%.